Cargando…
The effects of aromatase inhibitors on lipids and thrombosis
Oestrogen is known to influence blood lipid levels and though its cardioprotective effects are less clear than once thought, there remains concern that reduction of oestrogen levels during hormonal treatment for breast cancer may have an adverse effect on cardiovascular risk. While tamoxifen has bee...
Autor principal: | Bundred, N J |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361692/ https://www.ncbi.nlm.nih.gov/pubmed/16100522 http://dx.doi.org/10.1038/sj.bjc.6602692 |
Ejemplares similares
-
Potential use of COX-2–aromatase inhibitor combinations in breast cancer
por: Bundred, N J, et al.
Publicado: (2005) -
Sequencing of aromatase inhibitors
por: Bertelli, G
Publicado: (2005) -
Bone loss and the aromatase inhibitors
por: Lester, J, et al.
Publicado: (2005) -
Role of aromatase inhibitors in breast cancer
por: Carpenter, R, et al.
Publicado: (2005) -
The World Health Organization and Global Health Governance: post-1990
por: Lidén, J.
Publicado: (2014)